# AdvanSix share price today (AdvanSix Inc., ASIX)

> AdvanSix Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. ASIX · Materials · Chemicals · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/asix

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting worse, from the last 12 quarters
- Price: $15.58 (−16.2% in a year)
- P/E: 54.5×, over 1 year
- Revenue (Jun 2026): $421 M (+2.7% on a year ago)
- Profit (Jun 2026): $3.2 M (−89.6% on a year ago)
- Operating margin: 2.1% (−6.0 points on a year ago)
- ROE: 6%, FY25
- ROIC: 1.1%, against a 6.7% cost of capital: −5.6 points

The main question: yearly earnings per share moved +11.1% while the share price moved −16.2%. ## What is the AdvanSix share price today? AdvanSix Inc.'s share price was $15.58 at the close on 3 November 2026. That is 20.1% below its average price over the last 200 trading days. In the last 52 weeks it traded between $15 and $25, and at that close it sat 8% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 23 weeks running. Over the last 1 year the share price moved −33% while the S&P 500 moved +21%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 29 May 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does AdvanSix pay? AdvanSix Inc. paid $0.64 per share over the last four reported quarters. The most recent declaration was $0.16 for Jun 2026. At today's price of $15.58 that is a yield of 4.11%, based on dividends already paid, not a forecast. ## Which stock lists is AdvanSix on? AdvanSix is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is AdvanSix profitable? AdvanSix Inc. earned $3.2 M of net profit in the Jun 2026 quarter, −89.6% on the same quarter a year earlier. Full-year FY25 profit was $49.3 M. Over 4 years profit has grown −22.9% a year on average. That is 0.8% of the quarter's revenue. The same quarter a year earlier earned $31.4 M. 6 of the last 12 reported quarters were loss-making. For the full year, FY25 profit was $49.3 M (+11.6% on the year before). Why profit moved: revenue changed +2.7% on a year earlier and the margin moved −6.0 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed −315.2% and revenue +3.3%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does AdvanSix make, and is it growing? AdvanSix Inc. reported $421 M of revenue in the Jun 2026 quarter, +2.7% on the same quarter a year earlier. That is the 3rd quarter in a row with growth on the year before. Over 4 years it has grown −2.5% a year on average. The last full year, FY25, came in at $1.5 B. The last four reported quarters add to $1.6 B. FY25 revenue was $1.5 B, +0.3% on the year before. Recent pace: the last four quarters grew +3.3% on average, against −2.5% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +3.0%, against +2.1% a year over the last 8 quarters (stabilising). ## How much of every $100 of sales does AdvanSix keep? AdvanSix Inc.'s operating margin was 2.1% in the Jun 2026 quarter, 6.0 percentage points lower than the same quarter a year ago. Across 5 years it has been between 3.9% and 11.7%. The latest quarter is below every full year in that period. Why the margin moved: operating margin changed −6.0 percentage points on the year while gross margin changed −6.9 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is AdvanSix's profit turning into cash? Over the last 3 years, 254% of AdvanSix Inc.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $123 M of operating cash against $49.3 M of profit. After $116 M of spending on assets, $6.4 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does AdvanSix's cash go? AdvanSix Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $358 M on assets over the last 3 years. Averaged over those years that is 7.8% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $358 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is AdvanSix's P/E ratio, and how does it compare with its own history? AdvanSix Inc.'s P/E is 54.5×, with too little history to compare. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +11.1% while the price moved −16.2%. Earnings did better than the price, which pulled the multiple down within its own range. In short: there is too little history to say whether the multiple is high or low for this company, so the earnings trend underneath matters more than the multiple. ## Is the AdvanSix business getting better or worse? AdvanSix Inc.'s business is getting worse. Profit and EPS growth are shrinking: profit growth is −122.9% in the latest quarter, against +3634.7% at its best in 12 quarters, with ROCE falling at -1.0%. This is based on 12 quarters of 4 measures. Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind. ## How much does AdvanSix earn on its capital? AdvanSix Inc. earned a ROE of 6% in FY25. Its return on capital used (ROIC) is 5.6 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 3.2% net margin and 0.89× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 3.2% net margin × 0.89× asset turnover × 2.09× leverage (assets divided by equity) ≈ 6.0% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 1.1% − 6.7% = −5.6 percentage points. The 6.7% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The 1.1% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 4.8%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does AdvanSix have too much debt? AdvanSix Inc. has total debt of $424 M against shareholder equity of $797 M as of Jun 2026, so its debt is 0.53× its equity. Year by year, that ratio went from 0.45 in FY21 to 0.47 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the AdvanSix shareholding pattern? 2.4% of AdvanSix Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 2.2 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is AdvanSix from balance-sheet trouble? For AdvanSix Inc., the Z-score is 1.93. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the grey area between the two. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 1.93 is in the grey area, neither clearly safe nor clearly in trouble. ## How does AdvanSix rank in its industry? 32.8 out of 100, rank 14 of 15 in Chemicals, with 71% of the evidence available. AdvanSix Inc. scores 32.8 out of 100 against the 15 companies it is compared with in Chemicals, ranking 14. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 7.8 + 7.7 + 11 + 6.3 = 32.8. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is AdvanSix compared with? AdvanSix ranks 14 of 15 Chemicals companies on the 4-Factor Sector Score, with 32.8 out of 100. 1. [Methanex Corporation](https://www.sectoralpha.in/us/stocks/meoh) MEOH · breaking out · Most evidence points up · 81% evidence 75.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.8/35 · Revenue 19.2% · Profit -64.9% · Operating margin change 20.4 points · 83% evidence Capital efficiency 17.3/25 · ROCE 11.8% · Operating margin 37.1% · 76% evidence Valuation 14.0/20 · P/E 40.4× · PEG 0.17 · 65% evidence Relative strength 20.0/20 · Lead over its industry 47% · Lead over S&P 500 24.5% · 1 year 86.8% · 100% evidence · 8 of 12 weeks ahead Exact sum: 23.8 + 17.3 + 14 + 20 = 75.1 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [REX American Resources Corporation](https://www.sectoralpha.in/us/stocks/rex) REX · quiet · Most evidence points up · 85% evidence 70.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 27.4/35 · Revenue 1.2% · Profit 100% · Operating margin change 17.3 points · 95% evidence Capital efficiency 18.4/25 · ROCE 12.9% · Operating margin 22.4% · 76% evidence Valuation 14.7/20 · P/E 11.8× · PEG 0.25 · 65% evidence Relative strength 9.6/20 · Lead over its industry 9.1% · Lead over S&P 500 -7.8% · 1 year 22.8% · 100% evidence · 0 of 12 weeks ahead Exact sum: 27.4 + 18.4 + 14.7 + 9.6 = 70.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Westlake Chemical Partners LP](https://www.sectoralpha.in/us/stocks/wlkp) WLKP · turning · Most evidence points up · 81% evidence 67.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.4/35 · Revenue 12.1% · Profit 9.4% · Operating margin change -1.3 points · 83% evidence Capital efficiency 21.7/25 · ROCE 30.4% · Operating margin 29.4% · 76% evidence Valuation 10.1/20 · P/E 13.6× · PEG 1.57 · 65% evidence Relative strength 15.5/20 · Lead over its industry 14.2% · Lead over S&P 500 -3.2% · 1 year 16.5% · 100% evidence · 0 of 12 weeks ahead Exact sum: 20.4 + 21.7 + 10.1 + 15.5 = 67.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Dow Inc.](https://www.sectoralpha.in/us/stocks/dow) DOW · turning · Too little evidence to rank firmly · 58% evidence 57.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.8/35 · Revenue n/a · Profit n/a · Operating margin change 4.9 points · 45% evidence Capital efficiency 10.5/25 · ROCE 0.9% · Operating margin 6.8% · 76% evidence Valuation 10.8/20 · P/E -12.3× · PEG n/a · 15% evidence Relative strength 18.6/20 · Lead over its industry 23.9% · Lead over S&P 500 3.8% · 1 year 51.6% · 100% evidence · 3 of 12 weeks ahead Exact sum: 17.8 + 10.5 + 10.8 + 18.6 = 57.7 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 5. [Celanese Corporation](https://www.sectoralpha.in/us/stocks/ce) CE · turning · Evidence leans up · 64% evidence 55.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.2/35 · Revenue -2.2% · Profit n/a · Operating margin change 1.2 points · 62% evidence Capital efficiency 12.9/25 · ROCE 5.2% · Operating margin 11% · 76% evidence Valuation 10.1/20 · P/E -4.3× · PEG n/a · 15% evidence Relative strength 16.4/20 · Lead over its industry 14.6% · Lead over S&P 500 -3.9% · 1 year 21.9% · 100% evidence · 2 of 12 weeks ahead Exact sum: 16.2 + 12.9 + 10.1 + 16.4 = 55.6 · What this means: Relative strength against the index is -3.9%, and revenue and profit growth are weak. 6. [LSB Industries, Inc.](https://www.sectoralpha.in/us/stocks/lxu) LXU · turning · Evidence leans up · 64% evidence 54.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.6/35 · Revenue 22.1% · Profit n/a · Operating margin change -10.2 points · 62% evidence Capital efficiency 10.7/25 · ROCE 6.1% · Operating margin -1.6% · 76% evidence Valuation 9.2/20 · P/E 23.3× · PEG n/a · 15% evidence Relative strength 13.9/20 · Lead over its industry 11.8% · Lead over S&P 500 -6.6% · 1 year 29.6% · 100% evidence · 1 of 12 weeks ahead Exact sum: 20.6 + 10.7 + 9.2 + 13.9 = 54.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Green Plains Inc.](https://www.sectoralpha.in/us/stocks/gpre) GPRE · quiet · Evidence leans up · 64% evidence 53.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.6/35 · Revenue -23.7% · Profit n/a · Operating margin change 16.6 points · 62% evidence Capital efficiency 12.4/25 · ROCE 8.1% · Operating margin 15.2% · 76% evidence Valuation 9.9/20 · P/E 8.7× · PEG n/a · 15% evidence Relative strength 11.2/20 · Lead over its industry 11.7% · Lead over S&P 500 -6% · 1 year 39.2% · 100% evidence · 0 of 12 weeks ahead Exact sum: 19.6 + 12.4 + 9.9 + 11.2 = 53.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Valhi, Inc.](https://www.sectoralpha.in/us/stocks/vhi) VHI · quiet · Evidence leans down · 71% evidence 45.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 11.1/35 · Revenue 3.4% · Profit -127.5% · Operating margin change 7 points · 83% evidence Capital efficiency 9.2/25 · ROCE -0.4% · Operating margin 6.7% · 76% evidence Valuation 10.6/20 · P/E -8.1× · PEG n/a · 15% evidence Relative strength 14.3/20 · Lead over its industry 14.2% · Lead over S&P 500 -2.7% · 1 year 5% · 100% evidence · 5 of 12 weeks ahead Exact sum: 11.1 + 9.2 + 10.6 + 14.3 = 45.2 · What this means: Relative strength against the index is -2.7%, and revenue and profit growth are weak. 9. Ascent Industries Co. ACNT · quiet · Evidence leans down · 64% evidence 43.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.0/35 · Revenue 10.5% · Profit n/a · Operating margin change 8.2 points · 62% evidence Capital efficiency 4.5/25 · ROCE -6.6% · Operating margin -0.3% · 76% evidence Valuation 11.3/20 · P/E -30.6× · PEG n/a · 15% evidence Relative strength 8.4/20 · Lead over its industry 4.1% · Lead over S&P 500 -11.1% · 1 year 8.6% · 100% evidence · 2 of 12 weeks ahead Exact sum: 19 + 4.5 + 11.3 + 8.4 = 43.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [ASP Isotopes Inc.](https://www.sectoralpha.in/us/stocks/aspi) ASPI · quiet · Evidence leans down · 61% evidence 38.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.1/35 · Revenue 100% · Profit n/a · Operating margin change 331.6 points · 62% evidence Capital efficiency 3.0/25 · ROCE -19.2% · Operating margin -667.5% · 76% evidence Valuation 10.0/20 · P/E n/a · PEG n/a · 0% evidence Relative strength 0.3/20 · Lead over its industry -59.9% · Lead over S&P 500 -66.2% · 1 year -79.9% · 100% evidence · 0 of 12 weeks ahead Exact sum: 25.1 + 3 + 10 + 0.3 = 38.4 · What this means: Earnings are strong; relative strength in its sector is -59.9% and the one-year return is -79.9%. 11. [Olin Corporation](https://www.sectoralpha.in/us/stocks/oln) OLN · basing · Evidence leans down · 64% evidence 38.3 out of 100 Growth Capital Valuation Relative
12. [Huntsman Corporation](https://www.sectoralpha.in/us/stocks/hun) HUN · quiet · Evidence leans down · 64% evidence 37.4 out of 100 Growth Capital Valuation Relative
13. [Rayonier Advanced Materials Inc.](https://www.sectoralpha.in/us/stocks/ryam) RYAM · quiet · Most evidence points down · 64% evidence 33.4 out of 100 Growth Capital Valuation Relative
14. AdvanSix Inc. this page ASIX · basing · Most evidence points down · 71% evidence 32.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 7.8/35 · Revenue 2.9% · Profit -125% · Operating margin change -6 points · 83% evidence Capital efficiency 7.7/25 · ROCE -1% · Operating margin 2.1% · 76% evidence Valuation 11.0/20 · P/E -30.2× · PEG n/a · 15% evidence Relative strength 6.3/20 · Lead over its industry -6% · Lead over S&P 500 -21.3% · 1 year 1.3% · 100% evidence · 0 of 12 weeks ahead Exact sum: 7.8 + 7.7 + 11 + 6.3 = 32.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 15. [Tronox Holdings plc](https://www.sectoralpha.in/us/stocks/trox) TROX · quiet · Most evidence points down · 64% evidence 24.9 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Chemicals](https://www.sectoralpha.in/us/sectors/chemicals), all 15 compared on one page. ## Which companies are close to AdvanSix in size? AdvanSix is the 13th largest of 15 Chemicals companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Westlake Chemical Partners LP, Tronox Holdings plc, Rayonier Advanced Materials Inc. and Braskem S.A. Just below it: Valhi, Inc. and ASP Isotopes Inc. ### Chemicals companies close in size

1. [Westlake Chemical Partners LP](https://www.sectoralpha.in/us/stocks/wlkp) $768 million
2. [Tronox Holdings plc](https://www.sectoralpha.in/us/stocks/trox) $543 million
3. [Rayonier Advanced Materials Inc.](https://www.sectoralpha.in/us/stocks/ryam) $467 million
4. [Braskem S.A.](https://www.sectoralpha.in/us/stocks/bak) $454 million
5. AdvanSix Inc. $421 million
6. [Valhi, Inc.](https://www.sectoralpha.in/us/stocks/vhi) $414 million
7. [ASP Isotopes Inc.](https://www.sectoralpha.in/us/stocks/aspi) $277 million

[All 15 Chemicals companies, largest first](https://www.sectoralpha.in/us/sectors/chemicals#all-companies)

### Companies close in size in other industries

1. [Chiron Real Estate Inc.](https://www.sectoralpha.in/us/stocks/xrn) $416 million · REIT - Healthcare Facilities
2. [Materialise NV](https://www.sectoralpha.in/us/stocks/mtls) $415 million · Software - Application
3. AdvanSix Inc. $415 million
4. [Bed Bath & Beyond, Inc.](https://www.sectoralpha.in/us/stocks/bbby) $415 million · Specialty Retail
5. [C4 Therapeutics, Inc.](https://www.sectoralpha.in/us/stocks/cccc) $415 million · Biotechnology

## What else do people ask about AdvanSix? ### What were AdvanSix's latest quarterly results? AdvanSix Inc. reported revenue of $421 M and net profit of $3.2 M for the Jun 2026 quarter. Revenue rose 2.7% and profit fell 89.6% compared with a year earlier. Earnings per share were $0.12. The operating margin was 2.1%, 6.0 percentage points lower than a year earlier (as of 3 November 2026). ### What is AdvanSix's market cap? AdvanSix Inc.'s market capitalisation is $421 M at a stock price of $15.58. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is AdvanSix performing? AdvanSix Inc.'s latest readings are below. In its latest quarter, revenue rose 2.7% and profit fell 89.6% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 23 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Will AdvanSix's stock price go up? This page does not forecast AdvanSix Inc.'s stock price. What it shows instead: the stock price is $15.58. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Where is AdvanSix in its business cycle? AdvanSix Inc.'s FY25 operating margin was 4.0%, against a 5-year range of 3.9% to 11.7%: the low end of its own range, which is often where recoveries start. The latest quarter was 2.1%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the AdvanSix story? The main question: yearly earnings per share moved +11.1% while the share price moved −16.2%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is AdvanSix a stock worth studying right now? What the numbers show: AdvanSix Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether the price catches up with earnings that have already grown. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.